Last Updated: August 2, 2026

PIROXICAM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Piroxicam patents expire, and when can generic versions of Piroxicam launch?

Piroxicam is a drug marketed by Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Pharmobedient, SCS, Solis Pharms, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences. and is included in twenty-two NDAs.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Piroxicam

A generic version of PIROXICAM was approved as piroxicam by TEVA on December 11^th, 1992.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PIROXICAM?
What are the global sales for PIROXICAM?
What is Average Wholesale Price for PIROXICAM?

Summary for PIROXICAM

US Patents:	0
Applicants:	18
NDAs:	22

US Patents and Regulatory Information for PIROXICAM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Lifesciences	PIROXICAM	piroxicam	CAPSULE;ORAL	205585-001	Jul 17, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva	PIROXICAM	piroxicam	CAPSULE;ORAL	074131-002	Dec 11, 1992	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm Industries	PIROXICAM	piroxicam	CAPSULE;ORAL	073536-001	Mar 12, 1993		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms	PIROXICAM	piroxicam	CAPSULE;ORAL	074103-001	Aug 28, 1992		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva	PIROXICAM	piroxicam	CAPSULE;ORAL	073637-001	Jan 28, 1994		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Breckenridge	PIROXICAM	piroxicam	CAPSULE;ORAL	208991-001	Feb 21, 2018		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.